Chicago Fire Department firefighters🧑‍🚒 had the opportunity to get screened for #COPD at Station 18.   In this @GoHealio Exclusive, we spoke with representatives from: ⭐@COPDFoundation ⭐Ignite the Spirit ⭐@CFDMedia ⭐@nddMedical ⭐@RushMedical https://t.co/Fge9bZvg30

💬"Results of this subgroup analysis of patients with Asian race were consistent with the overall ASPEN study results in directionality,” Martina Flammer, MD, MBA, @Insmed, told Healio. #bronchiectasis #brensocatib https://t.co/PC9MPS8nTJ

30.4% of providers did not know the three most common causes of chronic #cough, but 87.6% knew that refractory chronic cough is a diagnosis of exclusion, Dr. Su Bunniran of @GSK said at #CHEST2025. @accpchest https://t.co/V7lNCzdK4h

Knowledge gaps about refractory chronic #cough and its epidemiology persist among health care providers, indicating a need for more education and treatment options, Dr. Su Bunniran of @GSK said at #CHEST2025. @accpchest https://t.co/V7lNCzdK4h

🗨️"This approval provides a valuable new treatment option for high-risk #PAH patients, particularly those with advanced, end-stage disease," Dr. Mohammed Andaleeb Chowdhury, @katztemplemed, said in a Healio Perspective. https://t.co/PolSbMq438

Asian patients with non-cystic fibrosis #bronchiectasis had a lower annualized exacerbation rate and less lung function decline with 52-week #brensocatib vs. placebo, according to data presented at #CHEST2025.   https://t.co/PC9MPS8nTJ   @accpchest @Insmed @ProfJDChalmers

GLP-1 receptor agonists target inflammation independent of weight, improving exacerbations and reducing the need for prednisone among patients with asthma and obesity, Dr. Sunanda Tah of @CamdenClarkMC said at #CHEST2025. @accpchest @EndocrineToday https://t.co/jsoNxjcbUq

💬"This is a low burden intervention that did not require any additional hiring of staff … and was found to have an increase in both reach and effectiveness,” Alexandra Khodadadi, MD, @WashUMedPCCM, said at #CHEST2025. #SmokingCessation https://t.co/OY6XpDgPIX

Patients with #obesity and #asthma who used #GLP1 receptor agonists had significantly fewer exacerbations and prednisone use than those who used prednisone alone, Dr. Sunanda Tah of @CamdenClarkMC said at #CHEST2025. @accpchest @EndocrineToday https://t.co/jsoNxjcbUq

Patients with #asthma admitted for an exacerbation who used #marijuana had an increase in mortality, but the increase was not statistically significant, Dr. Juan F. Martinez Ortega of Lincoln Medical Center said at #CHEST2025. @accpchest @jmartinezo93 https://t.co/zBcsXyZyiX

🚨FDA NEWS🚨 The FDA approved a label update for Winrevair (@Merck) to include that it lowers the risk for clinical worsening events in adults with advanced #PAH. 💬Dr. Mohammed Andaleeb Chowdhury, @katztemplemed, shares his thoughts on the news. https://t.co/PolSbMq438

@MUCOPHILE

Last week, Mike Hess, MPH, RRT, RPFT, of @COPDFoundation was at Station 18 🚒 to administer spirometry to Chicago’s Bravest 🧑‍🚒 and screen them for respiratory disease. Check out our exclusive interview below. @CFDMedia

💬"We demonstrated that adults with #COPD have higher rates of acquiring #pneumonia over a 12-month timeframe if they are actively smoking cigarettes🚬,” William He, MD, @IcahnMountSinai & @ColumbiaMSPH, said at #CHEST2025. https://t.co/shPVdGNzPp

Patients with #asthma who used #marijuana experienced more severe exacerbations based on their need for mechanical ventilation, Dr. Juan F. Martinez Ortega of Lincoln Medical Center said at #CHEST2025. @accpchest @jmartinezo93 https://t.co/zBcsXyZyiX

Presented at #CHEST2025: A tobacco treatment program included in electronic health records significantly raised treatment reach and the percentage of patients who achieved #smoking abstinence🚭.   https://t.co/OY6XpDgPIX   @accpchest @WashUMedPCCM

Mean ACQ-6 scores fell from 2.6 at baseline to 1.5 at week 28 and to 1.4 at week 52 with #tezepelumab, Dr. Sandeep Bansal of Penn Highlands Healthcare said at #CHEST2025. #asthma @accpchest @Amgen @AstraZeneca https://t.co/xren8Vwoj7

🧑‍🚒Firefighters face greater risks for respiratory disease. Last week, Jaimee Burgess, RRT/RCP of @nddMedical joined @COPDFoundation to screen Chicago’s Bravest at Station 18. 🚒 Check out the video below and stay tuned for our full report. https://t.co/ygoahyjKpo

Patients who depended on oral corticosteroids to care for their severe #asthma experienced improvements in asthma control after initiating treatment with #tezepelumab, Dr. Sandeep Bansal of Penn Highlands Healthcare said at #CHEST2025. @accpchest https://t.co/xren8Vwoj7

At #CHEST2025: A significant link was found between active #cigarette #smoking🚬 and an elevated rate of #pneumonia in #COPD, whereas this was not true for active e-cigarette or cigar smoking. @accpchest https://t.co/shPVdGNzPp